ArticleMaterials today. Bio2026
Mitochondria-targeted cuproptosis-driven nanoplatform for synergistic photothermal/chemodynamic therapy and systemic antitumor immunotherapy.
Hui Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.